Risankizumab (Severe chronic plaque psoriasis): Injection 150 mg in 1 mL pre-filled pen, Injection 150 mg in 1 mL pre-filled syringe, Injection 75 mg in 0.83 mL pre-filled syringe; Skyrizi^®

Page last updated: 1 July 2022

• Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 500KB)
• Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 83KB)